Growing up really is hard to do – especially for a small med-tech company in a big pond – but ICU Medical Inc. has "finally delivered" in a transformative way, according to analysts reacting to ICU's $1 billion deal to acquire Pfizer Corp.'s infusion therapy business, Hospira Infusion Systems. Read More
